Cadrenal Therapeutics, Inc. CVKD
Set alert
1.04 USD 0.00 0.00%
At close · Nov 2
1.00 -0.04 -3.85%
After hours · Nov 2, 4:00 PM ET
0.923 Day range 1.23
0.816 52-week range 13.37
- YTD
- -84.66%
- 1 year
- -92.39%
- Open
- 0.923
- Prev close
- 1.04
- Mkt cap
- 3.71M
- Vol
- 284.87K
- Avg vol
- 473.07K
- EPS
- -4.91
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.923
- High
- 1.23
- Forward P/E
- -3.02
- Beta
- 0.00
- Short ratio
- 1.17
- Inst. own
- 4.75%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 7, 2024
- 50-d avg
- 14.77
- 200-d avg
- 9.61
- 1y target
- 35.67
Held by funds
3 US ETFs and mutual funds hold CVKD · largest positions
Ownership
Held by insiders 34.06%
Held by institutions 4.75%
Float held by institutions 7.20%
Institutions 4
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Royal Bank of Canada | 0.00% | 25 | 356 | Sep 29, 2024 |
| Bank of America Corporation | 0.00% | 5 | 71 | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.19% | 3,216 | 45.86K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.07% | 1,109 | 15.81K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.06% | 923 | 13.16K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.00% | 60 | 855 | Sep 29, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| MURPHY JOHN RAYMOND | Director | Purchase | Oct 4, 2023 | 614,792 |
| PHAM QUANG X | Chief Executive Officer | Stock Gift | Apr 9, 2024 | 6,275,000 |
| SZOT MATTHEW K | Chief Financial Officer | Stock Award(Grant) | Jan 23, 2023 | 500,000 |
| WILSON GLYNN | Director | Conversion of Exercise of derivative security | Jan 23, 2023 | 50,000 |
